1. Academic Validation
  2. A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in α1-adrenergic receptor-induced p38 activation

A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in α1-adrenergic receptor-induced p38 activation

  • J Biol Chem. 2011 Mar 11;286(10):7925-7937. doi: 10.1074/jbc.M110.185645.
Luca Cariolato 1 Sabrina Cavin 1 Dario Diviani 2
Affiliations

Affiliations

  • 1 From the Département de Pharmacologie et de Toxicologie, Faculté de Biologie et Médecine, University of Lausanne, Lausanne 1005, Switzerland.
  • 2 From the Département de Pharmacologie et de Toxicologie, Faculté de Biologie et Médecine, University of Lausanne, Lausanne 1005, Switzerland. Electronic address: Dario.diviani@unil.ch.
Abstract

The mitogen-activated protein kinases (MAPKs) pathways are highly organized signaling systems that transduce extracellular signals into a variety of intracellular responses. In this context, it is currently poorly understood how kinases constituting these signaling cascades are assembled and activated in response to receptor stimulation to generate specific cellular responses. Here, we show that AKAP-Lbc, an A-kinase anchoring protein (AKAP) with an intrinsic Rho-specific guanine nucleotide exchange factor activity, is critically involved in the activation of the p38α MAPK downstream of α(1b)-adrenergic receptors (α(1b)-ARs). Our results indicate that AKAP-Lbc can assemble a novel transduction complex containing the RhoA effector PKNα, MLTK, MKK3, and p38α, which integrates signals from α(1b)-ARs to promote RhoA-dependent activation of p38α. In particular, silencing of AKAP-Lbc expression or disrupting the formation of the AKAP-Lbc·p38α signaling complex specifically reduces α(1)-AR-mediated p38α activation without affecting receptor-mediated activation of other MAPK pathways. These findings provide a novel mechanistic hypothesis explaining how assembly of macromolecular complexes can specify MAPK signaling downstream of α(1)-ARs.

Figures